4//SEC Filing
Murray Dallan 4
Accession 0000950170-24-053837
CIK 0000873303other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 8:09 PM ET
Size
4.9 KB
Accession
0000950170-24-053837
Insider Transaction Report
Form 4
Murray Dallan
Chief Customer Officer
Transactions
- Sale
Common Stock
2024-05-02$140.00/sh−3,635$508,900→ 18,125 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0002022303
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 8:09 PM ET
- Size
- 4.9 KB